Pediatrix Medical Group, Inc.
Capital Structure and Liquidity Pediatrix has a debt-to-equity ratio of 0.66, indicating a moderate level of leverage. The company's current ratio of 1.66 suggests it has sufficient short-term assets to cover its short-term liabilities. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. ### Profitability and Returns The company's return on equity (ROE) is 19.1%, and its return on assets (ROA) is 7.36%. These figures are strong indicators of efficient use of equity and assets, respectively. The operating income of $208.81 million and net income of $165.39 million for FY2025 reflect solid profitability. These metrics are in line with the industry's preferred metrics for healthcare providers. ### Segments and Geographic Exposure Pediatrix operates primarily in the United States, with a focus on hospital-based care. The company's services are concentrated in obstetrics, maternal-fetal medicine, and neonatology. The financial data does not provide specific geographic revenue breakdowns, but the company's operations are largely domestic. ### Growth Trajectory The company's revenue for the nine months ended September 30, 2025, was $1.42 billion, a decrease from $1.51 billion in the same period in 2024. The net income for the nine months ended September 30, 2025, was $131.71 million, compared to a net loss of $129.55 million in the same period in 2024. This indicates a significant improvement in profitability, although revenue has declined. ### Risk Factors The company faces medium liquidity risk, as noted in the risk assessment. The risk of dilution is low, but the company has a revolving credit facility and long-term debt, which could impact its financial flexibility. The risk assessment also highlights the potential for restructuring and transformational expenses, which could affect future profitability. ### Recent Events Recent filings indicate that the company has been involved in restructuring and transformational activities, including the impairment of goodwill and long-lived assets. The company also reported a net gain on investments in divested businesses, which positively impacted its financial results. Additionally, the company has been repurchasing common stock, which could signal confidence in its future performance.
Business. Pediatrix Medical Group, Inc. provides physician services in newborn, maternal-fetal, and pediatric subspecialty care, primarily through hospital-based neonatal intensive care units (NICUs) and affiliated clinicians.
Classification. Pediatrix is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector and the Healthcare Facilities & Services industry, with a classification confidence of 0.92.
- Pediatrix has a strong return on equity (19.1%) and return on assets (7.36%), indicating efficient use of capital.
- The company's liquidity position is moderate, with a current ratio of 1.66, but net cash is negative after subtracting total debt.
- Pediatrix's profitability has improved significantly, with a net income of $165.39 million for FY2025.
- The company's operations are primarily domestic, with a focus on hospital-based neonatal and maternal-fetal care.
- Recent restructuring and transformational activities have impacted the company's financial results, including goodwill and long-lived asset impairments.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.